More people die from lung cancer than from breast, prostate, and colon cancers COMBINED. For most patients, lung cancer is already at an advanced stage when first detected and cannot be cured. Low dose CT screening can detect lung cancer at earlier stages in high risk patients and decrease risk of death from lung cancer by 20%.
Who should consider lung cancer screening?
What else do I need to know?
For high risk patients, low-dose CT screening is effective in reducing death from lung cancer. However, the process can be confusing and complicated. As pulmonary physicians specializing in lung nodule evaluation, we have the expertise and experience to guide you through this challenging process to obtain the best outcome.
Focus on Lung Nodules
We have a team of pulmonary physicians that specialize in lung nodule evaluation and diagnosis. We understand that lung cancer often becomes the main concern when lung nodule/s are found on imaging. However, there are many other causes of lung nodules that are not due to cancer. We provide expedited evaluation and diagnosis of patients with lung nodules to rapidly determine the cause of the nodule.
Coordination of Care
We are key participants in CPMC Lung Nodule Tumor Board which is co-founded and co-chaired by Dr. Chen. This is a weekly multidisciplinary conference attended by Pulmonologists, Radiologists, Thoracic Surgeons, Medical Oncologists, and Radiation Oncologists to discuss best approach to diagnose lung nodules and treat lung cancer. We collaborate closely with other CPMC physicians to provide the most advanced, least invasive procedures to diagnose and treat lung cancer, including bronchoscopy with endobronchial ultrasound guided needle aspiration (EBUS-TBNA), electromagnetic navigational bronchoscopy, CT guided needle aspiration, video assisted thoracoscopic surgery, and stereotactic radiotherapy.
San Francisco Lung & Sleep
Note: We will be moving in March, 2019 to:
1100 Van Ness Ave,
SF, CA 94109
2351 Clay Street
San Francisco, CA 94115
Mon-Fri, 9AM - 5PM